**vo **rdisk?s diabetes drug semaglutide cuts heart risk by 26 percent
 

**vo **rdisk?s diabetes drug semaglutide cuts heart risk by 26 percent
COPENHAGEN (Reuters) - **vo **rdisk's experimental injectable diabetes drug semaglutide reduced cardiovascular risk by 26 percent according to the keenly awaited results of a clinical trial released on Friday.http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...-c:F7zBnMyn0Lo http://feeds.feedburner.com/~ff/reut...-c:V_sGLiPBpWU
http://feeds.feedburner.com/~r/reute...~4/eOkBV4z1LWw